Citigroup, Cowen, Oppenheimer and Wedbush PacGrow assist with offering
By Devika Patel
Knoxville, Tenn., June 25 – Catabasis Pharmaceuticals, Inc. said it priced its $60 million initial public offering of stock with a $9 million greenshoe. The deal was announced May 13.
The company will sell 5 million common shares at $12.00 per share.
Citigroup Global Markets Inc. and Cowen and Co., LLC are the bookrunners.
Settlement is expected June 30.
Proceeds will be used for clinical development, working capital and other general corporate purposes.
The pharmaceutical company is based in Cambridge, Mass. The company intends to list its common stock on the Nasdaq under the symbol “CATB.”
| Issuer: | Catabasis Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $77 million
|
| Greenshoe: | $9 million, or 750,000shares
|
| Shares: | 5 million
|
| Price: | $12.00
|
| Warrants: | No
|
| Bookrunners: | Citigroup Global Markets Inc. and Cowen and Co., LLC
|
| Co-managers: | Oppenheimer & Co. Inc. and Wedbush PacGrow
|
| Announcement date: | May 13
|
| Pricing date: | June 25
|
| Settlement date: | June 30
|
| Stock symbol: | Nasdaq: CATB
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
